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Abstract: Our aim was to prepare antibiotic
loaded rods with biotechnologically produced
biodegradable polymers and use them in the
treatment of osteomyelitis by providing a high
local dose of antibiotic at the infected site. For
that purpose, first the production of PHB and
its copolymers (P(3HB-co-3HV) and P(3HBco-4HB)) by Alcaligenes latus and Alcaligenes
eutrophus in the shake-flask cultures and in a
fed-batch fermenter and their purification and
characterization were performed. The
polymers were then used in the preparation
of the sulbactam-cefoperazone loaded rods.
To predict the in vivo behavior of the
controlled release system, the in vitro release
kinetics of the rods were studied in PBS at
37¡C. Release from 50 % w/w loaded P(3HB-
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Introduction
Bone infections can be defined as the inflammation of
bone and surrounding cortical tissue. Management of
bone infections is difficult, often requiring multiple
surgical operations and prolonged and sometimes
repeated courses of antibiotic administration [1-6].
Conventional treatment using systemic antibiotics is
expensive, toxic and prone to complications, and the
eradication of microorganisms is very difficult with this
approach.
Another method that is currently in use is the
controlled antibiotic release to the infected site by
antibiotic-impregnated polymethylmethacrylate (PMMA)
beads. This method provides high local antibiotic
concentration at the desired area but requires an
additional surgical procedure since the non-biodegradable
PMMA beads must be removed after they release their
antibiotic content. This procedure, in addition to being
uncomfortable for the patient, increases the chance of
reinfection [1]. The disadvantages of additional surgery
would be eliminated if the local delivery system were
constructed from a biodegradable material.

co-3HV) and P(3HB-co-4HB) rods showed
that the drug was completely released in less
than 3 days. To retard the rate, dip coatings
of these rods using the same polymer solution
were done and the release profiles were
obtained. After coating, cumulative release
was about 70 % of its initial content at the
end of 12 days. It was concluded that PHB
and its copolymers may be a promising
alternative to the materials of petrochemical
origin in the treatment of osteomyelitis, due
to being biodegradable, and eliminating the
need for a second operation.
Key
Words:
polyhydroxyalkanoates,
Alcaligenes latus, Alcaligenes eutrophus,
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Polyhydroxyalkanoates (PHAs) are naturally occurring
polyesters produced as energy storage materials by many
bacteria. Their general structural formula is shown in
Figure 1. The most common representative is
polyhydroxybutyrate (PHB) together with the copolymer
containing hydroxyvalerate (PHBV). These microbial
polyesters have unique physicochemical properties such
as thermoplasticity, biodegradability, biocompatibility and
piezoelectricity. Recently, it has become of industrial
interest to evaluate these polyesters for a wide range of
medical applications [7].
In this study, 2 microorganisms, namely Alcaligenes
eutrophus and Alcaligenes latus, were used as producer
organisms. Both organisms can use inexpensive carbon
sources, which is important in industrial-scale production
[8]. The organisms show differences in their growth and
polymer production conditions but they were chosen
because of their high polymer production capacity. The
other criterium for their selection is the ease of the
separation of the polymer from cells.

535

Biosynthesis of Polyhydroxybutyrate and Its Copolymers and Their Use In Controlled Drug Release

if R: methyl, polyhydroxybutyrate

were kept constant. The cells were harvested after 48
and 72 h with A. latus and A. eutrophus, respectively.
Fed-batch Fermenter Studies

if R: ethyl, polyhydroxyvalerate

Figure 1.

The General Structure of PHAs.

Materials and Methods
Materials
P(3HB-co-3HV) copolymers containing up to 11.3 %
(mol) HV and P(3HB-co-4HB) copolymers containing up
to 9.5 % (mol) 4-HB were obtained by cultivation of A.
eutrophus and A. latus under controlled conditions.
Sulperazoneª (consists of sulbactam and cefoperazone
in 1:1 ratio), the selected wide spectrum antibiotic, was
obtained from Pfizer (Turkey) and was used as received.

Fermentative production of polyhydroxybutyrate
(PHB) and its copolymers was carried out in a 2-liter LH
fermentation system using A. latus as the producer
organism. Control of temperature, oxygen concentration,
pH and foam were automatic. In the reactor studies,
sucrose was added twice to the growth medium as the
sole carbon source at the beginning of the fermentation
and after nitrogen depletion. The operation conditions of
different runs were tabulated (Table 1). The medium was
inoculated with A. latus (40 mL per liter of fermentation
medium) and 12 h later, determination of sugar, nitrogen
and dry cell weight (DCW) were initiated (with 2 h
intervals). Temperature (30¡C) and agitation rate (500
rpm) were kept constant throughout the experiment.

Methods
The Biosynthesis of the Polymers
The polymer production conditions differ for the 2
organisms. When A. eutrophus cells were used, the
biosynthesis was realized in 2 steps. Firstly, the growth
of the cells was promoted since a high number of cells
was needed for high polymer yield. In this step, the cells
were grown until the late logarithmic phase. The second
step was the production step in which the polymer
production and deposition was encouraged by nutrient
deficiencies (i.e., nitrogen, phosphate, etc.). The grown
cells were collected and transferred to the production
medium. As the carbon source, fructose was used.
Valerolactone and 4-hydroxybutyrate were added to the
production medium as co-substrates for the production
of copolymers P(3HB-co-3HV) and P(3HB-co-4HB),
respectively.
Polymer production by A. latus cells was performed in
a single step in contrast to A. eutrophus cells because A.
latus is a growth-associated producer. Because of this
characteristic, A. latus cells were selected for the
biosynthesis of the polymers at the fed-batch reactor. The
production was realized by the addition of the extra
carbon source, sucrose, at the late logarithmic phase [9].
Shake-flask Studies

A. latus and A. eutrophus cells were cultivated in 250,
500 and 1000 mL media. The cultivation conditions,
temperature 30¡C and shaking speed 150-200 rpm,
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Table 1.

Operation Conditions of the Fermenter.

Sucrose (g/L)
Nitrogen (g/L)
Oxygen (%)

RUN 1

RUN 2

RUN 3

15 + 15
0.460
20

20 + 15
0.264
20

20 + 15
0.410
30

The polymer synthesized during fermentation was
monitored with the use of crotonic acid assay in 10 mL
samples. An equal amount of sample was filtered
(Whatman cellulose acetate filters, pore size: 0.45 µm),
dried in an oven (50¡C, 2 h) and weighed for DCW
determination. Ammonium nitrogen and sucrose analyses
were carried out with the filtrate. Ammonium nitrogen
concentration was measured using a Spectroquant 14752
Ammonium kit (Merck AG, Germany). For sucrose
determination, the sample was treated with glucose
oxidase and peroxidase after acid hydrolysis and using odianisidine dye. H2O2 production was monitored at 530
nm by UV-Vis spectrophotometry.
Extraction and Purification of the Polymers
After the cells were collected, they were lyophilized.
The dried cells were extracted for 6 h in chloroform to
achieve the destruction of the cells and solubilization of
polymer. Purification of the polymers was done by
precipitation of the polymers in alcohol. The precipitated
polymers were collected by filtration and dried at room
temperature.
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Results

Preparation of Sulperazone Loaded Rods
Rod preparation was carried out as described
elsewhere [10]. In brief, a fraction of the weighed
polymer powder was dissolved in chloroform and poured
into a mortar, and the rest of the polymer was mixed
with antibiotic to yield a 1:1 w/w drug to polymer ratio
(i.e., 50 % (w/w) loading). The paste formed was ground
until it was homogeneous. This was then put into a glass
mold to produce the final rod in the shape of a
rectangular prism (20 x 0.3 x 0.3 cm3). Following
complete evaporation and solidification, antibiotic rods of
the required dimension and weight (ca. 1.0 x 0.3 x 0.3
cm3 and 90±10 mg) were cut and stored in sealed bags
until use in further studies. In order to modify the release
behavior, a set of these rods was dip-coated twice using
the corresponding polymer solution (10% w/w in
chloroform).

In vitro Release Studies
Release studies were carried out in previously
autoclaved (121¡C, 14 min) flasks containing sterile PBS
solution (0.1M, pH: 7.4, 100 mL). The release behavior
of sulperazone loaded uncoated and coated rods were
investigated in a shaking waterbath (rate: 70 rpm)
maintained at 37¡C. At certain time intervals, aliquots
were taken from the release medium and their UV
absorbances were spectrophotometrically measured at
λmax=224 nm. Release profiles of triplicate samples
were constructed.

Polymer Production

Shake-Flask Studies
It was observed that the carbon:co-substrate ratio
played an important role in the polymer productivity. The
compositions that yielded maximum productivity are
given in Table 2. The highest result was obtained with A.
eutrophus cells as 71.5 % polymer recovery based on dry
cell weight. In that case, the primary carbon source was
fructose (16 g/L) and the co-substrate was butyricacid
lactone (4 g/L).

Fermenter Studies
The results of the fed-batch reactor are given in Table
3. The fermentation profile of Run 1 is given in Figure 2.
The results show that nitrogen was depleted after 15 h
and polymer production started at the 12th hour.
Between 12 h and 21 h, the polymer production rate was
maximum (0.0547 g PHB produced/ g DCW/ h), and
after that point it started to slow down and a second
stage, where the production rate was about 10 % of the
first stage (0.0055 g PHB produced/ g DCW/ h), was
reached.

Characterization of the Polymers
The composition and the molecular weight of the
produced polymers were investigated and the results are
summarized in Table 4.

Table 2.

YIELD
Substrate
(g/L)

F+4HBA (18+2)

WCW

DCW

Polymer Yield

Polymer Yield

(g/L)

(g/L)

(g/L)

(% w/w)

23.9 ± 1.7

8.3 ± 0.9

3.5 ± 0.7

42.6 ± 5.8

20.6 ± 4.5

7.2 ± 2.2

3.1 ± 1.6

41.2 ±12.1

17.2 ± 0.9

5.3 ± 0.4

1.8 ± 0.7

33.2 ±12.6

21.1 ± 4.2

7.2 ± 1.9

2.9 ± 1.3

39.1 ± 13.6

Polymer Production with Different
Co-substrates.

n:4
F+VL (18+2)
n: 8
S+VL (24+1)
n: 3
S+4HBA (24+1)
n: 7
F: fructose, 4HBA:4-hydroxybutyrate, S: sucrose, VL: valerolactone
WCW: wet cell weight, DCW: dry cell weight
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The Results of Fed-Batch Reactor.

In vitro Drug Release

YIELD
Run
No.

Polymer Yield
(g/L)

Polymer : DCW
(%)

13.70

4.61

33.60

RUN 2

7.91

2.83

35.80

RUN 3

13.60

6.43

47.30

Sucrose & DCW (g/L)

RUN 1

21 -

0.7

18 -

0.6

15 -

0.5

12 -

0.4

9-

0.3

6-

0.2

3-

0.1

00

PHB/DCW (g/g) & Nitrogen (g/L)

Dry Cell Weight
(g/L)

0.0
5

10

15

Sucrose

Figure 2.

20 25 30
Time (hour)

DCW

35

Nitrogen

40

45

PHB / DCW

The uncoated rods released their contents quite
rapidly. Release of the drug is apparently controlled only
by the solubility of the drug and the tortuosity of the
paths within the rods. Uncoated A. eutrophus (3HB-co3HV) rods (1:1 drug:polymer ratio) released all of their
drug contents in 24 h (Figure 3). Similar results were
obtained with the A. latus (3HB-co-4HB) rods. They
released their complete drug contents in 3 days (Figure
4). When uncoated rods were examined under SEM
before and after release (Figures 5a, b), it was observed
that before release, the antibiotic crystals were close to
the surface of the rods.

140
120
Sulperazone release (%)

Table 3.

100
80
60
40
20
0

The Fermentation Profile of Run 1; Production of PHB by
A. latus in Fed-Batch Fermenter.

0

2

4

6

8

10

12

14

Time (day)
coated

Table 4.

Polymer Properties.

Producer

Carbon Source and

PHA Type and

Organism

Amount

Composition

Weight

(g/L)

(% mol)

(daltons)

Figure 3.
Molecular

uncoated

Drug Release From Uncoated and Coated A. eutrophus
(3HB-co-3HV) rods.

120

A. eutrophus

F
F + VL

5

(10)

P(3-HB) 100.0

3.53 x 10

(18+2)

P(3HV-co-3HB)

3.31 x 10

5

11.3 : 88.7

A. eutrophus

F + 4-HB (18+2)

P(3HB-co-4HB)

5

2.91 x 10

90.5 : 9.5

A. latus

S

(15)

P(3-HB) 100.0

5

2.90 x 10

5

A. latus

S + VL

(24+1)

P(3-HB) 100.0

3.84 x 10

A. latus

S + 4-HB (24+1)

P(3HB-co-3HV)

2.90 x 10

Sulperazone release (%)

100
A. eutrophus

80
60
40
20
0
0

2

4

6

8

10

12

14

Time (day)

5

uncoated

coated

92.5 : 7.7
F: Fructose, S: Sucrose, 4HBA:4-hydroxybutyrate, VL: Valerolactone
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Figure 4.

Drug Release From Uncoated and Coated A. latus (3HB-co4HB) rods.
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The dip-coating procedure yielded a coating of 10.610.9 mg/cm2. Coating of the rods significantly reduced
the burst effect and resulted in a much slower release of
the antibiotic (Table 5).
Coated AE(3HB-co-3HV) samples released 70% of
their initial drug content in about 2 weeks (Figure 3). The
cumulative release versus time plot of the coated rods is
quite linear and the release rate calculated directly from
the slope was found to be 6.00 mg Sulperazone/day. The
A. latus (3HB-co-4HB) counterpart released about 72%
of the initial drug within 12 days (Figure 4) at a rate of
5.4 mg Sulperazone/day.
SEM micrographs of coated rods differed significantly
from the uncoated ones. A uniform surface porosity can
be seen on the coated rod surfaces (Figure 6a). After the

Table 5.

release, the honeycomb structure loosened and the
continuity was lost at several points (Figure 6b).
Discussion
In this study, biodegradable polyhydroxyalkanoate
polyesters were produced using A. eutrophus and A.
latus, which were extracted, and after purification, they
were characterized. Sulperazone loaded rods were then
prepared and their in vitro release behavior was
investigated to predict their behavior in vivo.
Polymer Production
In these preliminary studies, our aim was to
determine the optimum growth and production

Properties of the Antibiotic Loaded Rods.

Sample
(m.o. / polymer)
Coating
AE/(3HB-3HV)
UC
AE/(3HB-3HV)
C
AL/(3HB-4HB)
UC
AL/(3HB-4HB)
C

Weight of Rod
(mg)

Sulperazone
Content
(mg)

Coat Weight
(mg)

Percent Release (%)
in Duration (day)

85.5 ± 2.5

42.7 ± 1.3

-

100.5 ± 25.2

50.2 ± 12.6

115.2 ± 29.8

92.0 ± 8.1

46.0 ± 4.0

-

85.6 ± 0.1

42.8 ± 0.0

100.7 ± 1.1

113.5 ± 7.0
(1)
69.8 ± 19.9
(12)
100.8 ± 2.1
(3)
72.9 ± 1.4
(12)

AE: A. eutrophus, AL: A. latus, C: coated, UC: uncoated

a
Figure 5.

b

SEM Micrographs of Uncoated Rods Before (a) and After (b) Release.
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a
Figure 6.

SEM Micrographs of Coated Rods Before (a) and After (b) Release.

conditions. It was observed that by increasing
oxygenation, the time necessary for the whole process
decreased, an important achievement for industrial
production. Sucrose (30 g/L) was depleted in 42 h at 20
%O2 (Run 1), whereas when it was increased to 35 g/L
and O2 was adjusted to 30%, the complete utilization
period could be reduced to 36 h (Run 3).
It can be seen that the initial nitrogen amount is also
important. After nitrogen depletion, there was no
significant cell growth, indicating that at low nitrogen
concentrations the corresponding number of cells was
also low, which in turn would reflect on the overall
polymer yield. For example, when the initial nitrogen was
0.46 g/L, DCW was 13.7 g/L (Run 1) and when it was
0.26 g/L, the DCW was reduced to 7.91 g/L (Run 2).
Therefore, even if the polymer to DCW ratio were high,
there would not be much polymer to recover and this is
not desirable.
An important finding, worth studying in detail, is the
effect of O2 concentration on polymer yield. The resultant
DCWs in Runs 1 and 3 were quite close and furthermore,
the C-source in Run 3 was slightly higher than in Run 1
(30 g/L vs 35 g/L). The polymer yield, however, was
found to be ca. 1.5-fold higher in Run 3 than Run 1,
which represents an increase higher than that expected
from the difference in the amount of C-sources. This
increase can be correlated with the increase in the O2
supplied to the fermenter (from 20% to 30%, an
increase of 50%). A possible explanation could be an
increase in efficiency of the enzyme system that is
involved in the synthesis of PHA from simple C-sources.
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The increase in O2 supply creating an additional stress
condition, and forcing the organism to deposit PHA at a
much higher efficiency and rate could be offered as
another explanation for this observation.

In vitro Release Studies
Two polymers were used in the in vitro release studies
and it was seen that both the polymers had the same
release profile. The release rate, however, was highly
affected by the presence of the coat around the antibiotic
loaded road.
High release rates exhibited by the uncoated PHA rods
may be desired at the beginning of the implant-related
osteomyelitis therapy because the efficiency of the
antibiotic often depends on the maintenance of high drug
concentrations at the site of infection. This is especially
true for initial effect. The release behavior of the
uncoated rods may provide the high drug concentrations
required at the beginning of the therapy. The lower but
more constant releases can be provided by the coated
rods to maintain the asceptic conditions.
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